1) Composition for preventing or treating cancer comprising TRAIL-secreting mesenchymal stem cells and compound C (10-2312414-0000) (2021.10.06)

2) Composition for preventing or treatingglioblastoma comprising cannabinoids and immune checkpoint inhibitors (10-2022-0009406) (2022.01.21)

3) Patient-derived meningioma organoids and method for preparing thereof (PCT/KR2022/020241) (2022.02.10)

4) Method for predicting the efficacy of treatment effects in glioblastoma by T cells (10-2615797, PCT/KR2022/020248) (2022.04.28)

5) B7-H3 targeted gamma delta chimeric antigen receptor T-cells and their use in glioblastoma treatment (10-2023-0167600) (2023.12.28)

6) Surgical site compression device including air flow pipe (10-2024-0147609) (2024.10.25)

7) Device and method for predicting shunt surery results for patients with normal pressure hydrocephalus based on artifical intelligence model (10-2024-0146140) (2024.10.23)